Physician profile
Bruce Spiess
NPI 1962596288
$34,306.06
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $8,632 · 2021: $8,669 · 2022: $3,250 · 2023: $3,405 · 2024: $21.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,265 · Food and Beverage: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,264.80 |
| Food and Beverage | $162.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols Shared Services North America, INC. | $10,113.07 | 2019-2020 | |
| Grifols, S.A. | $9,612.57 | 2019-2023 | Albutein |
| Hemosonics LLC | $9,135.30 | 2019-2023 | Quantra Qplus System |
| Octapharma USA, INC. | $5,099.64 | 2020 | |
| Baxter Healthcare | $123.73 | 2019 | |
| Haemonetics Corporation | $112.88 | 2019-2020 | |
| Werfen USA LLC | $87.22 | 2023 | |
| Quest Medical INC. | $21.65 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Spiess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.